Prostate cancer, accolades for two IOR researchers

A research project on prostate cancer conducted at the Institute of Oncology Research (IOR, affiliated to USI), won a PCF Challenge Award 2019 worth $1 million at the annual conference of the PCF Prostate Cancer Foundation, the leading U.S. agency in the field, on October 25 in Carlsbad, California. The study of the international research team, led by Prof. Andrea Alimonti, group leader at the IOR...
More

IOR receives important funding from SNSF to advance its prostate cancer research efforts

Dr. Giuseppina M. Carbone, Prostate Cancer Biology Group, receives a 4-year grant of 700’000 CHF from Swiss National Science Foundation (SNSF) to study a transcription factor that acts as tumor suppressor to prevent development of aggressive prostate tumors in men. Dr. Carbone has a longstanding record of accomplishment in investigating the role of ETS transcription factors in prostate cancer. ...
More

Swiss Cancer Research grant to Dr. Luciano Cascione

Dr. Luciano Cascione, head of Bioinformatics Core Unit at the Institute of Oncology Research and at the Swiss Institute of Bioinformatics (SIB), has received a research grant by the Swiss Cancer Research to study an enigmatic and interesting class of non-coding RNA called ultra-conserved regions (UCRs) in B-cell lymphomas. UCRs are 100% identical (fully conserved) across human and rodent genomes s...
More

A Swiss Cancer Research grant to Prof. Francesco Bertoni

Prof. Francesco Bertoni has received a three-years financial support to study the mechanism of resistance to the combination of copanlisib and venetoclax in marginal zone lymphomas. The project, with PD Anastasios Stathis and Prof. Andrea Alimonti as co-applicants, follows the design of the phase I study SAKK 66/18 (NCT03886649). The trial has indeed just opened the recruitment and is based on Pro...
More